Showing results (1-10 of 1,391) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|October 14, 2022
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting ReportJosee-Lyne Ethier, Katherine C Fuh, Rebecca Arend, et al.
JCO Precision Oncology|February 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk NeuroblastomaYvette A H Matser, Atia Samim, Marta Fiocco, et al.
JCO Precision Oncology|February 21, 2025
Genomic and Immune Landscape of Non-Small Cell Lung Cancer Brain MetastasesManlu Liu, Justin C Jagodinsky, S Carson Callahan, et al.
JCO Precision Oncology|January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Matthew R Smith, Fred Saad, et al.
JCO Precision Oncology|January 31, 2025
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast CancersArielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe, et al.
JCO Precision Oncology|January 8, 2025
Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch SyndromeLeah H Biller, Kate Mittendorf, Miki Horiguchi, et al.
JCO Precision Oncology|January 8, 2025
Molecular Profiling of Biliary Tract Cancers in African American and Caucasian PatientsZishuo Ian Hu, Dean C Pavlick, Jeffrey S Ross, et al.
JCO Precision Oncology|January 8, 2025
Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on SurvivalYing Li, Youliang Weng, Zongwei Huang, et al.
JCO Precision Oncology|January 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical TrialsStephen J Luen, Lauren C Brown, Courtney T van Geelen, et al.
JCO Precision Oncology|December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Pageof 140